![Bioorganic & Medicinal Chemistry Letters Referencing Guide · Bioorganic & Medicinal Chemistry Letters citation (updated Feb 23 2023) · Citationsy Bioorganic & Medicinal Chemistry Letters Referencing Guide · Bioorganic & Medicinal Chemistry Letters citation (updated Feb 23 2023) · Citationsy](https://citationsy.com/styles/img/bioorganic-and-medicinal-chemistry-letters.png?width=1360&height=700&style=Bioorganic%20&%20Medicinal%20Chemistry%20Letters)
Bioorganic & Medicinal Chemistry Letters Referencing Guide · Bioorganic & Medicinal Chemistry Letters citation (updated Feb 23 2023) · Citationsy
![Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 2, Pages 53-230 (15 January 2018) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 2, Pages 53-230 (15 January 2018) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X17X00255-cov200h.gif)
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 2, Pages 53-230 (15 January 2018) | ScienceDirect.com by Elsevier
![Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01159/asset/images/medium/jm0c01159_0002.gif)
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
![Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01159/asset/images/large/jm0c01159_0005.jpeg)
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
![Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X11X00215-cov200h.gif)
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier
This article was originally published in a journal published by Elsevier, and the attached copy is provided by Elsevier for the
![PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255] PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]](https://i1.rgstatic.net/publication/332830620_Corrigendum_to_'Synthesis_and_biological_evaluation_of_Doxorubicin-containing_conjugate_targeting_PSMA'_Bioor_Med_Chem_Lett_2910_2019_1246-1255/links/60084c9192851c13fe2413ca/largepreview.png)
PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]
Corrigendum to “Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture
![Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X16X00145-cov200h.gif)
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier
![Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 22, Pages 5001-5454 (15 November 2015) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 22, Pages 5001-5454 (15 November 2015) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X15X00217-cov200h.gif)
Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 22, Pages 5001-5454 (15 November 2015) | ScienceDirect.com by Elsevier
![PDF) Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554] | Joseph Vacca and Georgia McGaughey - Academia.edu PDF) Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554] | Joseph Vacca and Georgia McGaughey - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42029221/mini_magick20190218-15107-4ct7rc.png?1550499632)
PDF) Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554] | Joseph Vacca and Georgia McGaughey - Academia.edu
![PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47033617/mini_magick20190208-16001-acsyt1.png?1549613596)
PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu
![Bioorganic & Medicinal Chemistry Letters | Vol 14, Issue 9, Pages 2005-2374 (3 May 2004) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 14, Issue 9, Pages 2005-2374 (3 May 2004) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X00X02843-cov200h.gif)
Bioorganic & Medicinal Chemistry Letters | Vol 14, Issue 9, Pages 2005-2374 (3 May 2004) | ScienceDirect.com by Elsevier
![PDF) Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959] PDF) Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959]](https://i1.rgstatic.net/publication/257419056_Corrigendum_to_New_PPARg_ligands_based_on_barbituric_acid_Virtual_screening_synthesis_and_receptor_binding_studies_Bioorg_Med_Chem_Lett_18_2008_4959/links/59f4a712458515547c21c6df/largepreview.png)
PDF) Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959]
![Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 1, Pages 1-152 (1 January 2015) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 1, Pages 1-152 (1 January 2015) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X14X00259-cov200h.gif)
Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 1, Pages 1-152 (1 January 2015) | ScienceDirect.com by Elsevier
![Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X18X00134-cov200h.gif)